The relationship between perioperative administration of inhaled corticosteroid and postoperative respiratory complications after pulmonary resection for non-small-cell lung cancer in patients with chronic obstructive pulmonary disease

General Thoracic and Cardiovascular Surgery

Volumn 63, Issue 12, 2015, Pages 652-659

  Yamanashi, Keiji ^a   Marumo, Satoshi ^a   Shoji, Tsuyoshi ^b   Fukui, Takamasa ^a   Sumitomo, Ryota ^a   Otake, Yosuke ^a   Sakuramoto, Minoru ^a   Fukui, Motonari ^a   Huang, Cheng Long ^a  

^a Kitano Hospital   (Japan)

^b OTSU RED CROSS HOSPITAL   (Japan)

Author keywords

Inhaled corticosteroid; Lung cancer surgery; Postoperative respiratory complications

Indexed keywords

CORTICOSTEROID;

ACUTE HEART INFARCTION; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANGINA PECTORIS; ARTICLE; ATELECTASIS; ATRIAL FIBRILLATION; BRONCHOPLEURAL FISTULA; CANCER SURGERY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; HEART VENTRICLE TACHYCARDIA; HUMAN; INCIDENCE; LUNG LOBECTOMY; LUNG RESECTION; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PNEUMONIA; POSTOPERATIVE COMPLICATION; PROPENSITY SCORE; RECURRENT LARYNGEAL NERVE PALSY; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SEGMENTECTOMY; THROMBOEMBOLISM; VERY ELDERLY; ARTIFICIAL VENTILATION; CARCINOMA, NON-SMALL-CELL LUNG; COMPLICATION; EPIDEMIOLOGY; INHALATIONAL DRUG ADMINISTRATION; LUNG DISEASES; LUNG NEOPLASMS; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATIONS; PROCEDURES; PULMONARY ATELECTASIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY INSUFFICIENCY; TRACHEOSTOMY; VIDEO ASSISTED THORACOSCOPIC SURGERY;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; MALE; PERIOPERATIVE CARE; PNEUMONECTOMY; PNEUMONIA; POSTOPERATIVE COMPLICATIONS; PULMONARY ATELECTASIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY INSUFFICIENCY; THORACIC SURGERY, VIDEO-ASSISTED; TRACHEOSTOMY;

EID: 84949091335     PISSN: 18636705     EISSN: 18636713     Source Type: Journal    
DOI: 10.1007/s11748-015-0593-0     Document Type: Article

References (22)

1. Jen R, Rennard SI, Sin DD. Effects of inhaled corticosteroids on airway inflammation in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2012;7:587–95.
2. Sugiura H, Ichinose M, Yamagata S, Koarai A, Shirato K, Hattori T. Correlation between change in pulmonary function and suppression of reactive nitrogen species production following steroid treatment in COPD. Thorax. 2003;58:299–305.
3. Sin DD, McAlister FA, Man SF, Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA. 2003;290:2301–12.
4. Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009;34:380–6.
5. Yamada Y, Sekine Y, Suzuki H, Iwata T, Chiyo M, Nakajima T, et al. Trends of bacterial colonisation and the risk of postoperative pneumonia in lung cancer patients with chronic obstructive pulmonary disease. Eur J Cardiothorac Surg. 2010;37:752–7.
6. Sekine Y, Behnia M, Fujisawa T. Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC. Lung Cancer. 2002;37:95–101.
7. Belda J, Cavalcanti M, Ferrer M, Serra M, Puig de la Bellacasa J, Canalis E, et al. Bronchial colonization and postoperative respiratory infections in patients undergoing lung cancer surgery. Chest. 2005;128:1571–9.
8. Duque JL, Ramos G, Castrodeza J, Cerezal J, Castanedo M, Yuste MG, et al. Early complications in surgical treatment of lung cancer: a prospective, multicenter study. Grupo Cooperativo de Carcinoma Broncogenico de la Sociedad Espanola de Neumologia y Cirugia Toracica. Ann Thorac Surg. 1997;63:944–50.
9. Turner MO. Inhaled corticosteroids and pneumonia in COPD: an association looking for evidence. Am J Respir Crit Care Med. 2008;177:555–6 (author reply 556).
10. Drummond MB, Dasenbrook EC, Pitz MW, Murphy DJ, Fan E. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA. 2008;300:2407–16.
11. Woodhead M. Inhaled corticosteroids cause pneumonia…or do they? Am J Respir Crit Care Med. 2007;176:111–2.
12. Ernst P, Gonzalez AV, Brassard P, Suissa S. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med. 2007;176:162–6.
13. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347–65.
14. Nojiri T, Inoue M, Yamamoto K, Maeda H, Takeuchi Y, Funakoshi Y, et al. B-type natriuretic Peptide as a predictor of postoperative cardiopulmonary complications in elderly patients undergoing pulmonary resection for lung cancer. Ann Thorac Surg. 2011;92:1051–5.
15. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356:775–89.
16. Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ. 2000;320:1297–303.
17. Whitford H, Orsida B, Kotsimbos T, Pais M, Ward C, Zheng L, et al. Bronchoalveolar lavage cellular profiles in lung transplantation: the effect of inhaled corticosteroids. Ann Transplant. 2000;5:31–7.
18. van Rensen EL, Straathof KC, Veselic-Charvat MA, Zwinderman AH, Bel EH, Sterk PJ. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma. Thorax. 1999;54:403–8.
19. Tinkelman DG, Bronsky EA, Gross G, Schoenwetter WF, Spector SL. Efficacy and safety of budesonide inhalation powder (Pulmicort Turbuhaler) during 52 weeks of treatment in adults and children with persistent asthma. J Asthma. 2003;40:225–36.
20. Kew KM, Seniukovich A. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014;3:CD010115.
21. Decramer ML, Hanania NA, Lotvall JO, Yawn BP. The safety of long-acting beta2-agonists in the treatment of stable chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2013;8:53–64.
22. Jeon JH, Kang CH, Kim HS, Seong YW, Park IK, Kim YT, et al. Video-assisted thoracoscopic lobectomy in non-small-cell lung cancer patients with chronic obstructive pulmonary disease is associated with lower pulmonary complications than open lobectomy: a propensity score-matched analysis. Eur J Cardiothorac Surg. 2014;45:640–5.